Overview
Anti-viral drugs are used to treat viral infections and are the only agents acting against viruses as either other drugs are ineffective or too toxic. The market segment of anti-viral drugs is driven by factors such as rise in healthcare expenditure, growing research and development investment, emergence of virus life-threatening diseases like bird flu, strong development pipeline and increasing incidence rates of viral infections particularly HIV. WHO has estimated that in 2015 about 36.7 million people are suffering from HIV/AIDS with 1.1 million deaths occurring due to AIDS-related illness the emergence of donor funding in the treatment of the disease has also increased the demands of anti-viral drug market. Strong research pipeline coupled with rise in research and development investment will be the market driver of the future.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2454
The constraints on the market include side effects associated with treatment, the cost of the therapy and poor efficacy and effectiveness of the drugs.
Segmentation
The global anti-viral drugs market has been segmented based on application and mechanism of action. By application, the market has been segmented into hepatitis, HIV/AIDS, herpes, influenza and others. By mechanism of action, the market has been segmented into nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, and others.
Regional Analysis
The Americas, Europe, Asia Pacific, and Middle East & Africa are the key markets for antiviral drugs. The Americas is the largest market followed by Europe. Growing prevalence of viral infections in the region, the presence of key players in the region and high healthcare expenditure drives the market in the Americas.
The Europe market is driven by the presence of a robust healthcare sector and high investment in R&D activities.
Asia Pacific is slated to be the fastest growing market for anti-viral drugs. Growing prevalence of viral infections in the developing economies of the region coupled with the outlay of massive amounts on healthcare facilities supports the growth of the Asia Pacific market.
Competitive Landscape
The anti-viral drugs market is supported by growing research and development investment. The population growth around the world and increasing demand of anti-viral drugs market based services and products also support the market growth. However, changes in policies and lack of clarity in guidelines can affect the market growth. The report covers all such details which will help companies in the anti-viral drugs market to strengthen their business plan and improve their product portfolio. The anti-viral drugs market research report also provides company profiles of major companies. The company profiles of many organizations operating in the anti-viral drugs market report highlights crucial details like company size, revenue growth, and details of mergers and acquisitions taking place in the anti-viral drugs market. New companies and established businesses can plan their strategies based on this data provided in the anti-viral drugs market research report.
Industry News
NeuroBo Pharmaceuticals, a biotechnology firm, has announced that it has purchased ANA Therapeutics, a privately owned biotechnology company that produces a patented niclosamide capsule formulation for the indication of coronavirus, now in Phase 2/3 clinical trials as a cure for COVID-19. The deal was unanimously approved by both the Boards of Directors of NeuroBo Pharmaceuticals and ANA Therapeutics
Key Players:
The major participants of this market are: Johnson & Johnson, Merck & Co. Inc., Gilead Sciences Inc., Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Abbott Laboratories, Novartis International AG, AstraZeneca AB, Cipla Inc. and others.
List of Tables
TABLE 1 GLOBAL ANTI-VIRAL DRUGS MARKET, 2020-2027 (USD MILLION)
TABLE 2 GLOBAL ANTI-VIRAL DRUGS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL ANTI-VIRAL DRUGS MARKET, BY MECHANISM OF ACTION, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL ANTI-VIRAL DRUGS MARKET, BY REGION, 2020-2027 (USD MILLION)
Browse Complete Report @ https://www.marketresearchfuture.com/reports/anti-viral-drugs-market-2454
Related reports link:-
Global Hemorrhoid Treatment Devices Market
Veterinary Vaccines Market
Microcarriers Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
